Inventor · disambiguated record
Jing Cui
Also filed as: CUI JING · CUI JING Z
5 granted patents·4 pending applications·15 citations·filing 2001–2024
70Inventor score
Files withASCLEA CORP1BEIJING XINJI JINNUO MEDICAL EQUIPMENT CO LTD1OAISCELL BIOTECHNOLOGIES1RADICAL VISION THERAPEUTICS IN1SHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD1
Top patents by PatentIndex Score
9 records- 0178US8809300B2Depolymerized glycosaminoglycan from Thelenota ananas and preparation method thereofZHAO JINHUA·Filed 2010·Granted Aug 19, 2014·5 cites·20 claims
- 0253US2024310382A1Standard Characteristic Polypeptide Sequence for Quantitatively Detecting Casein Glycomacropeptide in Polypeptide Product by Mass SpectrometryWUXI INST FOR FOOD CONTROL·Filed 2024·Application pending·0 cites
- 0351US2022195487A1Method for Measuring Inhibition of Bacteria by Antibacterial Drug, and Bacterial Counting Device and Method ThereofBEIJING XINJI JINNUO MEDICAL EQUIPMENT CO LTD·Filed 2020·Application pending·0 cites
- 0450US2021346430A9Method for treating glioblastomaOAISCELL BIOTECHNOLOGIES·Filed 2019·Application pending·0 cites
- 0548US7754765B2Copper chelators for treating ocular inflammationRADICAL VISION THERAPEUTICS IN·Filed 2003·Granted Jul 13, 2010·10 cites·27 claims
- 0645US10668069B2Pharmaceutical composition comprising neptinib or salt thereof and method for controlling impurity thereofSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2017·Granted Jun 2, 2020·0 cites·7 claims
- 0741US2003055113A1Copper chelators for treating ocular inflammationFiled 2001·Application pending·0 cites
- 0839US11351185B2Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasisASCLEA CORP·Filed 2020·Granted Jun 7, 2022·0 cites·17 claims
- 0923US12133931B2Bioactive scaffold for inducting tendon regeneration, preparation method therefor and use thereofWEST CHINA HOSPTIAL SICHUAN UNIV·Filed 2017·Granted Nov 5, 2024·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Jing Cui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →